Lifecare ASA: Share capital increase registered

25 Mar 2026 13:49 CET

Reference is made to the stock exchange announcement by Lifecare ASA (the
"Company") on 13 March 2026 regarding the result following expiry of the
exercise period for the warrants series 1 with ISIN NO0013709196 ("Warrants
Series 1") issued in connection with the partially underwritten rights issue
of new shares in the Company completed in January 2026.

A total of 107,059,776 Warrants Series 1 were exercised at the exercise price
of NOK 0.3342 per share, raising gross proceeds of NOK 35,779,377.14.

The share capital increase pertaining to the issuance of new shares as a
result of the exercised Warrants Series 1 has now been registered with the
Norwegian Register of Business Enterprises. The Company's new share capital is
NOK 29,812,074.90 divided into 298,120,749 shares, each with a nominal value
of NOK 0.10.

The new shares are expected to be delivered to the VPS accounts of the
subscribers to whom they are allocated on or about 26 March 2026, subject to
timely payment having been received.

About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring systems to market. Lifecare
enables osmotic pressure as sensing principle. Lifecare's sensor technology is
suitable for identifying and monitoring the occurrence of a wide range of
analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42

This information is subject to disclosure under the Norwegian Securities
Trading Act, §5-12. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-03-25 13:49 CET.

More information:
Access the news on Oslo Bors NewsWeb site

669277_Lifecare ASA- Share capital increase registered.pdf